\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Emergence of Allium Cepa as Antitubercular Agent},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2015-05-15 (revised: 15 May 2015)}
\def\TheID{\makeatother }
\def\TheDate{2015-05-15}
\title{Emergence of Allium Cepa as Antitubercular Agent}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Shashidhar  Mehta}

             \affil[1]{  Mewar University}

\renewcommand\Authands{ and }

\date{\small \em Received: 9 April 2015 Accepted: 4 May 2015 Published: 15 May 2015}

\maketitle


\begin{abstract}
        


 Tuberculosis (TB)  Tuberculosis (TB) is the main cause of morbidity in modern era and a latent infection affecting nearly one third of world?s population including forty percent from India. There is an urgent need to explore the effective and promising new antiâ??" tubercular drugs to combat against Tuberculosis. Nature provides diverse secondary metabolites with anti- tubercular activity in medicinal plants. Among them Allium cepa (onion)., contains various constituents like quercetin, fructose, quercetin-3-glucoside, isorhamnetin-4-glucoside, xylose, galactose, glucose, mannose, organosulfur compounds, allylsulfides, flavonoids, flavenols, S-alk(en)yl cysteine sulfoxides, cycloalliin, selenium, thiosulfinates, and sulfur and seleno compounds that have proved to have protective role in tuberculosis. Allium cepa (onion) possesses antibiotic activity against both Gram-positive and Gram-negative bacteria and can be used to prevent tuberculosis most effectively.

\end{abstract}


\keywords{}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{I. Introduction}]{I. Introduction}\par
uberculosis (TB) has emerged as one of the most serious and devastating that contributes the great loss of life and has been growing on pandemic rate. Medicinal plants have been used from long back the centuries and thus have shown very promising results. They have been used as pure as a raw material and thus have been elucidated. Out of the numerous plants, a small fraction has been screened out for their therapeutic efficacy. India has a rich culture with widespread use of herbal drugs for their elucidation of the mechanistic role that proves to be effective. The increase in the resistance of MDR and XDR further warrants the urge for the discovery of new drug that can be effectively screened out for the benefit of the mankind.\par
The issue of multidrug resistance has been increasing at an alarming rate. Mutation either at the genetic level or the transcriptional level leads to various deregulations that have been associated with the concept of multi drug resistance. The inculpation of the chemotherapy in the management of MDR-TB ensures the high risk of toxicity that is posing more dangerous to the mankind.\par
The second line drugs used to treat TB has been associated with great probability of drug resistance. This led to various devastations that further poses damage to the health of an individual. The WHO recommends the use of herbs in order to combat the various types of resistance so that therapeutic effect can be attained without compromising the quality of the life care of the patient. The worldwide research conducted on a number of plants gave very promising results and thus can be explored to attain the therapeutic benefits.\par
Allium cepa (onion) has been used in India from long centuries before and is almost exclusively used throughout the world. Research conducted on various studies suggest the ole of Allium cepa as antimicrobial, anti-cancer, antioxidant, antidiabetic, antihypercholestrolemic, anti hyperglycemic, anti mutagenic, cicatrizant effects, hemostatic, osteoclastic and anti-cardiovascular effects and thus gave very effective results. The effect of Allium cepa against gram positive and gram negative microorganisms like Escherichia, Salmonella, Staphylococcus, Streptococcus, Klebsiella, Proteus, Bacillus, clostridium, Helicobacter pylori and even acid-fast bacilli (AFB) have shown their utmost important role.\par
The use of onion as promising medicinal plants has been further demonstrated in various Ayurveda and Greek system of medicine. The presence of various constituents in the onion makes it an effective therapeutic target for a wide array of diseases. However, the much research has been further needed to exploit the further hidden mechanism and modulatory role of pathways by which Allium cepa shows the promising role.\par
The use of herbal drugs in India has been traced back long before the centuries and thus they have been used on a large demand. The use of MDR resistance has been growing and thus there is an urge for all the researchers to combat the disease by discovering new therapeutic targets. The various research has been carried through out the world to study the effect of Allium cepa to assess itsbeneficial role. The promising result given by Allium sativumnecessitates the further exploitation of the effect of Allium cepa that can be extrapolated if possible for the benefit of mankind. 
\section[{II. Pathophysiology of Tuberculosis}]{II. Pathophysiology of Tuberculosis}\par
M. tuberculosis requires the presence of oxygen to grow. It does not require the presence of any bacteriological stain due to high lipid content in its wall, and thus is never considered as Gram-positive nor Gram-negative; hence Ziehl-Neelsen staining, or acidfast staining, is used extensively and too a wide extent. The mycobacteria do not seem to fit the Gram-positive category from an empirical standpoint i.e., they do not retain the crystal violet stain, they are classified as acidfast Gram-positive bacteria due to their lack of an outer cell membrane.\par
M. tuberculosis replicates in every 15-20 hours, which is extremely at a slow rate compared to other bacteria, which tend to have rapid division times measured in minutes. Specifically, M. tuberculosis blocks the bridging molecule, early endosomalautoantigen 1 (EEA1); however, this blockade does not prevent fusion of vesicles filled with nutrients. Consequently, the bacteria rapidly multiply unchecked within the macrophage. The bacteria also carried the UreC gene, which prevents the acidification of the phagosome. The bacteria also evade macrophage-killing by causing the neutralization of reactive nitrogen intermediates. 
\section[{III. Promising Role of Herbal Drugs}]{III. Promising Role of Herbal Drugs}\par
Rifambicin, ethombutol, isoniazid and pyracinamide has been used as the current therapy for TB but the emergence of problem of multiple drug resistant (MDR) and (XDR) strains of mycobacterium is very used to with these drugs and poses a serious problem. The presence of "cross resistance" cause no single drug or combination therapy was able to control TB to a maximal account and such drug resistance is developed only against purified chemical compounds and has given successful results. The purified compounds cause the existence of resistance in pathogens and thus have proved to be effective against such diseases. Mycobacteriae are having self regulation to digest the drug by altering their receptor structure in response to the chemical structure of the drug. Thus the Mycobacteriae adapt at a very less rate and develop resistance against the new and modern drugs. The existence of herbal drug whether in the form of extract or decoction used against any pathogen will not cause the occurrence of drug resistance and thus can be eventually used in the therapy as an antitubercular drug. Hence an effective and appropriate drug therapy as an anti tuberculosis drug need to be evaluated and thus can be used to overcome the problem of cross resistance and can be used for the benefit. 
\section[{IV. Discussion}]{IV. Discussion}\par
The appearance of tuberculosis not only in India but in whole world is increasing at an alarming rate. The appearance of various resistant strains like MDR and XDR further mandates the exploration of new and promising therapy for the beneficial effect and in reducing the various mortalities and morbidities. Thus, urgent need of various studies are the need of the day to assess isolates/strains of M. tuberculosis as well as fractions of crude extract/ purified/semi-purified priniciple in order to evaluate their therapeutic role and thus serve the effect for the health status of the mankind. 
\section[{V. Conclusion}]{V. Conclusion}\par
The side effects associated with the allopathic drugs have remarkdly necessities the need of herbal drugs. The various side effects and serious morbidities associated with allopathic drugs further necessitates the need of the day to explore various effective and safe therapies that can be used as a promising agent . In the present review, authors have tried to make a complete description of allium cepa asantitubercular drugs around the globe. The various constituents present in plants makes them as an effective antitubercular drug. The discovery of new drugs has finally begin to emerge, the standard of care for tuberculosis might become possible soon Although the prevalence of TB in the society exists from long back centuries, still new and promising research needs to be evaluated out for the benefit of the society and improving the status of the healthcare.		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[Newton et al. ()]{b6}\label{b6} 	 		‘A review of antimycobacterial natural products’.  		 			S M Newton 		,  		 			C Lau 		,  		 			C W Wright 		.  	 	 		\textit{Phytother Res}  		2000. 14 p. .  	 
\bibitem[Canetti et al. ()]{b10}\label{b10} 	 		‘Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes’.  		 			G Canetti 		,  		 			W Fox 		,  		 			A Khomenko 		,  		 			H T Mahler 		,  		 			N K Menon 		,  		 			D A Mitchision 		.  	 	 		\textit{Bull World Health Organ}  		1969. 41 p. .  	 
\bibitem[Gupta and Chopra ()]{b8}\label{b8} 	 		‘Anti-tubercular action of Adhatodavasica (N.O. acanthacea)’.  		 			K C Gupta 		,  		 			I C Chopra 		.  	 	 		\textit{Indian J Med Res}  		1954. 42 p. .  	 
\bibitem[Shivakumar (2011)]{b15}\label{b15} 	 		‘Anti-tuberculosis activity of commonly used medicinal plants of south’.  		 			A Shivakumar 		,  		 			Jayaraman 		.  	 	 		\textit{India Journal of Medicinal Plants Research}  		23 December, 2011. 5  (31)  p. .  	 
\bibitem[Gupta et al. ()]{b7}\label{b7} 	 		‘Anti-tuberculosis activity of selected medicinal plants against MDR-MTB isolates INDIAN’.  		 			Renu Gupta 		,  		 			Bandana Thakur 		,  		 			Pushpender Singh 		,  		 			H B Singh 		,  		 			V D Sharma 		,  		 			V M Katoch 		,  		 			S V S Chauhan 		.  	 	 		\textit{J MED RES}  		June2010. 131 p. .  	 
\bibitem[Jain ()]{b9}\label{b9} 	 		‘Antitubercular activity of garlic oil’.  		 			R C Jain 		.  	 	 		\textit{Indian drugs}  		1993. 30 p. .  	 
\bibitem[Kent and Kubica ()]{b11}\label{b11} 	 		‘Antituberculosis chemotherapy and drug susceptibility testing in public health mycobacteriology: a guide for the level III laboratory. Atlanta GA: US Department of Health and Human Services’.  		 			P T Kent 		,  		 			G P Kubica 		.  	 	 		\textit{Centers for Disease Control and Prevention}  		1985. p. .  	 
\bibitem[Heinrich and Gibbons ()]{b2}\label{b2} 	 		‘Ethnopharmacology in drug 3. discovery: an analysis of its role and potential contribution’.  		 			M Heinrich 		,  		 			S Gibbons 		.  	 	 		\textit{J Pharm Pharmacol}  		2001. 53 p. .  	 
\bibitem[Werngren et al. ()]{b13}\label{b13} 	 		‘Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis’.  		 			J Werngren 		,  		 			L Klintz 		,  		 			S E Hoffner 		.  	 	 		\textit{J Clin Microbiol}  		2006. 44 p. .  	 
\bibitem[Lall and Meyer]{b14}\label{b14} 	 		\textit{In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants},  		 			N Lall 		,  		 			J J Meyer 		.  		 	 
\bibitem[Gautam et al. ()]{b5}\label{b5} 	 		‘Indian medicinal plants as a source of antimycobacterial agents’.  		 			R Gautam 		,  		 			A Saklani 		,  		 			S M Jachak 		.  	 	 		\textit{J Ethnopharmacol}  		2007. 110 p. .  	 
\bibitem[Agarwal ()]{b0}\label{b0} 	 		‘Inter-sectoral cooperation for success of the RNTCP’.  		 			S P Agarwal 		.  	 	 		\textit{Indian J Tuberc}  		2004. 51 p. .  	 
\bibitem[Bemer et al. ()]{b12}\label{b12} 	 		‘Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis’.  		 			P Bemer 		,  		 			T Bodmer 		,  		 			J Munzinger 		,  		 			M Perrin 		,  		 			V Vincent 		,  		 			H Drugeon 		.  	 	 		\textit{J Clin Microbiol}  		2004. 42 p. .  	 
\bibitem[Sharma ()]{b4}\label{b4} 	 		\textit{National Academy of Ayurveda, Ministry of Health and Family Welfare, Government of India},  		 			S K Sharma 		.  		1998. New Delhi, India.  	 	 (Medicinal plants used in Ayurveda) 
\bibitem[Gupta and Tandon ()]{b3}\label{b3} 	 		\textit{Reviews of Indian medicinal plants},  		 			A K Gupta 		,  		 			N Tandon 		.  		2004. New Delhi, India: Indian Council of Medical Research.  	 
\bibitem[Singh ()]{b1}\label{b1} 	 		‘XDR-TB-Danger ahead Indian’.  		 			M M Singh 		.  	 	 		\textit{J Tuberc}  		2007. 54 p. .  	 
\end{bibitemlist}
 			 		 	 
\end{document}
